Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: To highlight the potential importance of advanced glycation endproducts (AGEs) and advanced-lipoxidation endproducts (ALEs) in obesity and obesity-related complications, and the contribution of the receptor for advanced glycation endproducts (RAGE) and the glyoxylase defense system therein. RECENT FINDINGS: Formation of AGEs/ALEs and its precursors, including methylglyoxal (MGO), are increased in conditions characterized by hyperglycemia, hyperlipidemia and enhanced oxidative stress. This metabolic profile is generally considered typical for obesity. Increased plasma and/or tissue levels of MGO and of specific AGEs/ALEs, such as N(ε)-(carboxymethyl)lysine (CML), in obesity have recently been described. In addition to increased formation, the suppressed defense system in obesity against AGEs/ALEs formation, that is, the glyoxylase system, will further contribute to AGEs/ALEs formation in obesity. AGEs/ALEs are not inert. In-vitro studies showed that AGEs induced the production of inflammatory mediators in adipocytes and macrophages via RAGE activation, which may subsequently contribute to the development of obesity-related complications. SUMMARY: The recognition of an enhanced AGEs/ALEs formation in adipose tissue and the biological consequences thereof may lead to a further understanding of underlying mechanisms in dysregulated production of adipokines in obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The formation of AGEs (the Maillard reaction) starts with the reaction of sugar aldehydes with the N-terminus of free-amino groups of proteins to form a so-called Schiff base [187].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [187]
In the citing paper
“The studies derived from these techniques evidence a net increased AGEs level in obesity [187], Diabetes Mellitus [207] and chronic inflammatory diseases, like Rheumatoid Arthritis [208], as well as in age-related diseases, such as cardiovascular, renal and neurodegenerative pathologies [193,209].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [187]
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“Unau 0957-9672 2013 Wolters Kluwer Health | Lippincott Williams & Wilk obesity-related inflammation and development of insulin resistance and type 2 diabetes in obesity [1,2].”
BackgroundBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597 · cited 2×
“Therefore, accelerated AGEs/ALEs formation is seen in diabetes, but also in age-related diseases, such as atherosclerosis and neurodegenerative disorders including Alzheimer’s disease [3,7].”
BackgroundAdipose tissue as an endocrine organ
Galic, S., Oakhill, J. S., & Steinberg, G. R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.018 · Cited by 1,562 · cited 2×
“Unau 0957-9672 2013 Wolters Kluwer Health | Lippincott Williams & Wilk obesity-related inflammation and development of insulin resistance and type 2 diabetes in obesity [1,2].”
BackgroundUnderstanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297 · cited 2×
“AGEs have been found to significantly reduce GLO1 expression and activity in cultured fibroblasts, endothelial cells and neuronal cells, whereas inhibition of RAGE restores GLO1 in these cells [21,22].”
BackgroundFormation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
Thornalley, P. J., LANGBORG, A., & Minhas, H. S. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440109 · Cited by 1,243 · cited 1×
“resulting in a very fast formation of specific AGEs within hours [9].”
BackgroundKislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Du Yan, S., Hofmann, M., Yan, S. F., Pischetsrieder, M., Stern, D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 869 · cited 1×
“As CML is a major ALE, and is an important ligand for RAGE that can activate RAGE-dependent signaling pathways [25], CML may be regarded as an important protein modification in obesity with significant effects on adipose tissue and adipocyte function.”
BackgroundFu, M.-X., Requena, J. R., Jenkins, A. J., Lyons, T. J., Baynes, J. W., & Thorpe, S. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9982 · Cited by 822 · cited 4×
“Modification of proteins originating from lipid peroxidation reactions produces characteristic ALEs, such as MDA-lysine and HNE-lysine, but also CML and CEL [8].”
BackgroundInfluentialNonenzymatic Browning in Vivo: Possible Process for Aging of Long-Lived Proteins
Monnier, V. M., & Cerami, A. (1981) · Science · doi:10.1126/science.6779377 · Cited by 764 · cited 2×
“believed that AGEs accumulate only on long-lived extracellular proteins [6].”
BackgroundDiabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 697
Glyoxalase I – structure, function and a critical role in the enzymatic defence against glycation
Thornalley, P. J. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311343 · Cited by 614 · cited 1×
“GLO1 is considered the key enzyme in the antiglycation defense [31].”
BackgroundReceptor for AGE (RAGE): Signaling mechanisms in the pathogenesis of diabetes and its complications
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06320.x · Cited by 521 · cited 1×
“protein (MAP) kinase signaling pathways [23].”
Glycoxidation and lipoxidation in atherogenesis
Baynes, J. W., & Thorpe, S. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00228-8 · Cited by 514 · cited 1×
“In addition to CML, it has been suggested that MGO is formed by lipid peroxidation [13].”
BackgroundShinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513 · cited 1×
“Unau 0957-9672 2013 Wolters Kluwer Health | Lippincott Williams & Wilk is believed to be the most potent glycation agent [11,12].”
BackgroundBierhaus, A., Fleming, T., Stoyanov, S., Leffler, A., Babes, A., Neacsu, C., Sauer, S. K., Eberhardt, M., Schnölzer, M., Lasitschka, F., et al. (2012) · Nature Medicine · doi:10.1038/nm.2750 · Cited by 495
Wardenburg, J. B., Fu, C., Jackman, J. K., Flotow, H., Wilkinson, S. E., Williams, D. H., Johnson, R., Kong, G., Chan, A. C., & Findell, P. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19641 · Cited by 463
Dicarbonyl Intermediates in the Maillard Reaction
THORNALLEY, P. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.014 · Cited by 459 · cited 4×
“Modification of proteins originating from lipid peroxidation reactions produces characteristic ALEs, such as MDA-lysine and HNE-lysine, but also CML and CEL [8].”
BackgroundInfluentialMethylglyoxal, glyoxalase 1 and the dicarbonyl proteome
Rabbani, N., & Thornalley, P. J. (2012) · Amino Acids · doi:10.1007/s00726-010-0783-0 · Cited by 430
Glucose and diabetic vascular disease 1
Ruderman, N. B., Williamson, J. R., & Brownlee, M. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.11.1644256 · Cited by 375
Cai, W., Ramdas, M., Zhu, L., Chen, X., Striker, G. E., & Vlassara, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205847109 · Cited by 325 · cited 1×
“[46] demonstrated that oral administration of MGO in mice resulted in adiposity and obesityrelated complications.”
BackgroundBierhaus, A., & Nawroth, P. P. (2009) · Diabetologia · doi:10.1007/s00125-009-1458-9 · Cited by 314 · cited 3×
“An important downstream gene of the AGE–RAGE axis is RAGE itself, that leads to a continued maintenance and amplifications of the signaling pathways and inflammatory events [22].”
BackgroundStructural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)
Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R., Burz, D. S., & Shekhtman, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801622200 · Cited by 252 · cited 2×
“Oligomerization of RAGE is required for the high-affinity binding of ligands [26] and plays a critical role in activation of RAGE and induction of downstream signaling pathways.”
BackgroundGlyoxalase in diabetes, obesity and related disorders
Rabbani, N., & Thornalley, P. J. (2011) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2011.02.015 · Cited by 249
RAGE Control of Diabetic Nephropathy in a Mouse Model
Myint, K.-M., Yamamoto, Y., Doi, T., Kato, I., Harashima, A., Yonekura, H., Watanabe, T., Shinohara, H., Takeuchi, M., Tsuneyama, K., et al. (2006) · Diabetes · doi:10.2337/db06-0221 · Cited by 249
Brouwers, O., Niessen, P. M., Ferreira, I., Miyata, T., Scheffer, P. G., Teerlink, T., Schrauwen, P., Brownlee, M., Stehouwer, C. D., & Schalkwijk, C. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144097 · Cited by 229
Self-citationWestwood, M. E., & Thornalley, P. J. (1995) · Journal of Protein Chemistry · doi:10.1007/bf01886793 · Cited by 226
Brouwers, O., Niessen, P. M., Haenen, G., Miyata, T., Brownlee, M., Stehouwer, C. D., De Mey, J. G., & Schalkwijk, C. G. (2010) · Diabetologia · doi:10.1007/s00125-010-1677-0 · Cited by 192 · cited 1×
“Furthermore, they showed in an ex-vivo model that hyperglycemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries can be improved by GLO1 overexpression [32].”
BackgroundSelf-citationUnoki‐Kubota, H., Bujo, H., Yamagishi, S., Takeuchi, M., Imaizumi, T., & Saitō, Y. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.09.016 · Cited by 161 · cited 2×
“Furthermore, the AGE–RAGE interaction inhibits glucose uptake in these adipocytes through the generation of intracellular reactive oxygen species [52].”
BackgroundBerner, A., Brouwers, O., Pringle, R., Klaassen, I., Colhoun, L. M., McVicar, C. M., Brockbank, S., Curry, J., Miyata, T., Brownlee, M., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2393-0 · Cited by 156
Self-citationMiyata, T., Inagi, R., Asahi, K., Yamada, Y., Horie, K., Sakai, H., Uchida, K., & Kurokawa, K. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01079-5 · Cited by 155 · cited 2×
“Modification of proteins originating from lipid peroxidation reactions produces characteristic ALEs, such as MDA-lysine and HNE-lysine, but also CML and CEL [8].”
BackgroundRole of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy
Jack, M. M., & Wright, D. E. (2012) · Translational research · doi:10.1016/j.trsl.2011.12.004 · Cited by 155
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.06.004 · Cited by 151
Song, Y., Manson, J. E., Tinker, L., Rifai, N., Cook, N. R., Hu, F. B., Hotamisligil, G. S., Ridker, P. M., Rodriguez, B. L., Margolis, K. L., et al. (2007) · Diabetes · doi:10.2337/db07-0250 · Cited by 148
Fleming, T. H., Humpert, P. M., Nawroth, P. P., & Bierhaus, A. (2011) · Gerontology · doi:10.1159/000322087 · Cited by 135
Structural and functional changes in human insulin induced by methylglyoxal
Jia, X., Olson, D. J. H., Ross, A. R. S., & Wu, L. (2006) · The FASEB Journal · doi:10.1096/fj.05-5478fje · Cited by 129 · cited 2×
“In addition to indirect effect of AGEs/ALEs on glucose metabolism leading to insulin resistance, glycation of insulin itself may change the properties of insulin [39,62].”
BackgroundSuccination of Protein Thiols during Adipocyte Maturation
Nagai, R., Brock, J. W., Blatnik, M., Baatz, J. E., Bethard, J., Walla, M. D., Thorpe, S. R., Baynes, J. W., & Frizzell, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703551200 · Cited by 122
Jia, X., & Wu, L. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9563-x · Cited by 110 · cited 2×
“In addition to indirect effect of AGEs/ALEs on glucose metabolism leading to insulin resistance, glycation of insulin itself may change the properties of insulin [39,62].”
BackgroundGaens, K. H. J., Niessen, P. M. G., Rensen, S. S., Buurman, W. A., Greve, J. W. M., Driessen, A., Wolfs, M. G. M., Hofker, M. H., Bloemen, J. G., Dejong, C. H., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.028 · Cited by 109
Self-citationSuccination of Thiol Groups in Adipose Tissue Proteins in Diabetes
Frizzell, N., Rajesh, M., Jepson, M. J., Nagai, R., Carson, J. A., Thorpe, S. R., & Baynes, J. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019257 · Cited by 99
Buetler, T. M., Leclerc, E., Baumeyer, A., Latado, H., Newell, J., Adolfsson, O., Parisod, V., Richoz, J., Maurer, S., Foata, F., et al. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700101 · Cited by 82
Plasma advanced glycation end products are decreased in obese children compared with lean controls
Šebeková, K., Somoza, V., Jarčušková, M., Heidland, A., & Podracká, L. (2009) · International Journal of Pediatric Obesity · doi:10.1080/17477160802248039 · Cited by 82 · cited 1×
“[40] found significantly lower CML plasma levels in obese children compared to lean controls.”
BackgroundSemba, R. D., Arab, L., Sun, K., Nicklett, E. J., & Ferrucci, L. (2011) · Journal of Nutrition · doi:10.3945/jn.111.143172 · Cited by 79 · cited 1×
“com Moreover, an inverse relationship between circulating CML and fat mass was recently reported [41], suggesting that enlargement of adipose tissue mass in obesity contributes to decreased CML plasma levels.”
BackgroundSanchez, J.-C., Converset, V., Nolan, A., Schmid, G., Wang, S., Heller, M., Sennitt, M. V., Hochstrasser, D. F., & Cawthorne, M. A. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200033-mcp200 · Cited by 77 · cited 1×
“In animal models of obesity, GLO1 was decreased in liver [47], in glomeruli [48] and in neuronal tissue [49].”
BackgroundUchida, Y., Ohba, K.-I., Yoshioka, T., Irie, K., Muraki, T., & Maru, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m304222200 · Cited by 74 · cited 1×
“In adipose tissue, AGEs stimulated PAI-1 and MCP-1 expression via RAGE-mediated generation of oxidative stress [50,52] In addition, an AGE-induced downregulation of leptin was observed in cultured adipocytes [51,53].”
BackgroundBarati, M. T., Merchant, M. L., Kain, A. B., Jevans, A. W., McLeish, K. R., & Klein, J. B. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00411.2006 · Cited by 74 · cited 1×
“In animal models of obesity, GLO1 was decreased in liver [47], in glomeruli [48] and in neuronal tissue [49].”
BackgroundIchikawa, K., Yoshinari, M., Iwase, M., Wakisaka, M., Doi, Y., Iino, K., Yamamoto, M., & Fujishima, M. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00221-9 · Cited by 68 · cited 1×
“These macrophages are a potential source of secreted inflammatory factors, and it has been demonstrated in macrophages that AGEs stimulate the production of cytokines, such as TNF-a [58,59].”
BackgroundMethylglyoxal Mediates Adipocyte Proliferation by Increasing Phosphorylation of Akt1
Jia, X., Chang, T., Wilson, T. W., & Wu, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036610 · Cited by 67
Ueno, H., Koyama, H., Shoji, T., Monden, M., Fukumoto, S., Tanaka, S., Otsuka, Y., Mima, Y., Morioka, T., Mori, K., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.04.006 · Cited by 65
Thornalley, P. J. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700017 · Cited by 62 · cited 1×
“what extent AGEs are intestinally absorbed and what the contribution is of exogenous sources of AGEs to the total concentration of AGEs in the body [19].”
BackgroundSuccination of proteins in diabetes
Frizzell, N., Lima, M., & Baynes, J. W. (2011) · Free Radical Research · doi:10.3109/10715762.2010.524643 · Cited by 59
Unoki-Kubota, H., Yamagishi, S.-I., Takeuchi, M., Bujo, H., & Saito, Y. (2010) · Protein & Peptide Letters · doi:10.2174/092986610791760423 · Cited by 54
Leuner, B., Max, M., Thamm, K., Kausler, C., Yakobus, Y., Bierhaus, A., Sel, S., Hofmann, B., Silber, R.-E., Simm, A., et al. (2012) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-011-0279-x · Cited by 52
Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice
Hagiwara, S., Gohda, T., Tanimoto, M., Ito, T., Murakoshi, M., Ohara, I., Yamazaki, T., Matsumoto, M., Horikoshi, S., Funabïki, K., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.033 · Cited by 48 · cited 1×
“[62,63] showed that MGO modification of insulin-reduced glucose uptake in”
BackgroundWu, C., Huang, H.-W., Huang, S.-M., Lin, J., Yeh, C., & Yen, G. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf201271y · Cited by 42 · cited 1×
“In 3T3-L1 adipocytes, AGEs cause insulin resistance by suppressing insulin-stimulated glucose uptake, which was reversed by anti-RAGE antibody [60].”
BackgroundChemical modification of proteins during peroxidation of phospholipids
Januszewski, A. S., Alderson, N. L., Jenkins, A. J., Thorpe, S. R., & Baynes, J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400442-jlr200 · Cited by 42
de la Maza, M. P., Uribarri, J., Olivares, D., Hirsch, S., Leiva, L., Barrera, G., & Bunout, D. C. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0786 · Cited by 39 · cited 1×
“Increased CML accumulation was also observed in skeletal muscles of obese patients, which was associated with weight gain [37].”
BackgroundPathological Roles of Advanced Glycation End Product Receptors SR‐A and CD36
HORIUCHI, S., UNNO, Y., USUI, H., SHIKATA, K., TAKAKI, K., KOITO, W., SAKAMOTO, Y., NAGAI, R., MAKINO, K., SASAO, A., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.076 · Cited by 39 · cited 1×
“In adipose tissue, AGEs stimulated PAI-1 and MCP-1 expression via RAGE-mediated generation of oxidative stress [50,52] In addition, an AGE-induced downregulation of leptin was observed in cultured adipocytes [51,53].”
BackgroundMaeda, S., Matsui, T., Takeuchi, M., & Yamagishi, S. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.08.043 · Cited by 32 · cited 1×
“Adiponectin expression levels were also decreased upon AGE incubation in adipocytes, which was mediated via RAGE-induced NADPH oxidase-generated oxidative stress [54].”
BackgroundRashid, G., Luzon, A.-A., Korzets, Z., Klein, O., Zeltzer, E., & Bernheim, J. (2001) · Peritoneal Dialysis International · doi:10.1177/089686080102100203 · Cited by 28
Skapare, E., Konrāde, I., Liepinsh, E., Makrecka‐Kuka, M., Zvejniece, L., Švalbe, B., Vilšķe̅rsts, R., & Dambrova, M. (2012) · The Journal of Physiological Sciences · doi:10.1007/s12576-012-0224-9 · Cited by 26 · cited 1×
“In animal models of obesity, GLO1 was decreased in liver [47], in glomeruli [48] and in neuronal tissue [49].”
BackgroundRole of Glucoxidation and Lipid Oxidation in the Development of Atherosclerosis
Schleicher, E. D., Weigert, C., ROHRBACH, H., Nerlich, M. L., Bachmeier, B. E., & Friess, U. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.041 · Cited by 24
Unno, Y., Sakai, M., SAKAMOTO, Y., Kuniyasu, A., Nagai, R., Nakayama, H., & Horiuchi, S. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.080 · Cited by 16
Lipid‐Derived Modifications of Plasma Proteins in Experimental and Human Diabetes
Januszewski, A. S., Jenkins, A. J., Baynes, J., & Thorpe, S. R. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.047 · Cited by 5
Research works printed but not linked: 1
- Song, 2007, RAGE regulates obesity and hyperglycmia induced by high-fat feeding in mice., Diabetes, 56, A451
Cited by
Manna, P., & Jain, S. K. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0095 · Cited by 1,145
“Ox-LDL-induced alteration in adipokine secretion can also induce CVD complications.(138) Higher OxLDL in obese subjects may be due to lower serum activity of antioxidant enzymes(139) or reduced PON-1 levels.”
BackgroundOxidative stress in obesity: A critical component in human diseases
Marseglia, L., Manti, S., D’Angelo, G., Nicotera, A., Parisi, E., Di Rosa, G., Gitto, E., & Arrigo, T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010378 · Cited by 933
“For example, Ox-LDL decreases the release of adiponectin, which inhibits ROS synthesis [101].”
BackgroundScheijen, J. L. J. M., Clevers, E., Engelen, L., Dagnelie, P. C., Brouns, F., Stehouwer, C. D. A., & Schalkwijk, C. G. (2016) · Food Chemistry · doi:10.1016/j.foodchem.2015.06.049 · Cited by 343
Self-citationShen, C.-Y., Lu, C.-H., Wu, C.-H., Li, K.-J., Kuo, Y.-M., Hsieh, S.-C., & Yu, C.-L. (2020) · Molecules · doi:10.3390/molecules25235591 · Cited by 301
“[47] reported that increased plasma and tissue levels of MGO, AGEs, and advanced lipoxidation end products (ALE) surrogated by CML were found in obesity.”
BackgroundThe Pathogenesis of Obesity-Associated Adipose Tissue Inflammation
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_9 · Cited by 287
Metadata
- Authors
- Gaens, K. H., Stehouwer, C. D., & Schalkwijk, C. G.
- Affiliations
- Maastricht University Medical Centre (NL)
- Corresponding author
- Schalkwijk, Casper G.
- Venue
- Current Opinion in Lipidology
- Published
- 2013-02
- Volume
- 24
- Issue
- 1
- Pages
- 4-11
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2048970664
- Cited by
- 166
- References
- 64
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 11 · 2023: 10 · 2022: 13 · 2021: 13 · 2020: 9 · 2019: 14 · 2018: 10 · 2017: 16 · 2016: 12 · 2015: 19 · 2014: 17 · 2013: 5
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- Nierstichting
- Center for Translational Molecular Medicine
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Keywords
- advanced glycation end products, receptor for advanced glycation end products, obesity, methylglyoxal, oxidative stress, hyperglycemia, hyperlipidemia, adipose tissue, inflammation, adipokines, obesity complications
- MeSH terms
- Receptor for Advanced Glycation End Products, Adipose Tissue, Humans, Hyperlipidemias, Lactoylglutathione Lyase, Macrophages, Obesity, Pyruvaldehyde, Receptors, Immunologic, Lipid Peroxidation, Signal Transduction, Glycation End Products, Advanced, Adipocytes, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.